Published in AIDS Res Hum Retroviruses on May 08, 2012
Genetic Analysis of HIV-1 Integrase Sequences from Treatment Naive Individuals in Northeastern South Africa. Int J Mol Sci (2013) 0.78
Lack of integrase inhibitors associated resistance mutations among HIV-1C isolates. J Transl Med (2015) 0.77
HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland. BMC Infect Dis (2012) 0.76
Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, Mozambique. AIDS Res Hum Retroviruses (2013) 0.75
Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS (2011) 6.26
Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. J Virol (2009) 2.19
Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors. Retrovirology (2008) 1.79
Resistance to integrase inhibitors. Viruses (2010) 1.75
Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants. Antiviral Res (2008) 1.61
Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector. Antimicrob Agents Chemother (2009) 1.03
Natural polymorphisms of integrase among HIV type 1-infected South African patients. AIDS Res Hum Retroviruses (2010) 0.93
Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children. AIDS Res Hum Retroviruses (2009) 0.89
Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. Virus Genes (2003) 0.82
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med (2005) 3.17
Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission. Pediatr Infect Dis J (2008) 3.02
Risk factors for incomplete vaccination and missed opportunity for immunization in rural Mozambique. BMC Public Health (2008) 2.36
CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry (2002) 2.25
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis (2012) 1.82
Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology (2006) 1.71
Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J Acquir Immune Defic Syndr (2014) 1.52
Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS (2003) 1.47
A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS (2003) 1.45
Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diagn Lab Immunol (2002) 1.40
Two lineages of dengue virus type 2, Brazil. Emerg Infect Dis (2010) 1.38
Vpr.A3A chimera inhibits HIV replication. J Biol Chem (2007) 1.37
Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV. J Int AIDS Soc (2009) 1.37
Developing laboratory systems and infrastructure for HIV scale-up: A tool for health systems strengthening in resource-limited settings. J Acquir Immune Defic Syndr (2009) 1.36
World Health Organization/HIVResNet Drug Resistance Laboratory Strategy. Antivir Ther (2008) 1.36
Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. J Infect Dis (2004) 1.35
Differential drug resistance acquisition in HIV-1 of subtypes B and C. PLoS One (2007) 1.23
Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases. Antimicrob Agents Chemother (2004) 1.23
Routine data from prevention of mother-to-child transmission (PMTCT) HIV testing not yet ready for HIV surveillance in Mozambique: a retrospective analysis of matched test results. BMC Infect Dis (2013) 1.23
HIV-1 subtype C dissemination in southern Brazil. AIDS (2005) 1.18
Assessment of routine surveillance data as a tool to investigate measles outbreaks in Mozambique. BMC Infect Dis (2006) 1.15
In vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir. Antimicrob Agents Chemother (2003) 1.14
Different epidemic potentials of the HIV-1B and C subtypes. J Mol Evol (2005) 1.12
A quality management systems approach for CD4 testing in resource-poor settings. Am J Clin Pathol (2010) 1.12
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. Antimicrob Agents Chemother (2006) 1.08
Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol (2008) 1.06
Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling. AIDS (2014) 1.05
Cholera epidemiology in Mozambique using national surveillance data. J Infect Dis (2013) 1.04
Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in southern Brazil. J Acquir Immune Defic Syndr (2003) 1.04
Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism. J Infect Dis (2005) 1.01
Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy. J Clin Microbiol (2002) 1.01
Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorer. Cytometry (2002) 0.99
The need for systematic evaluations of diagnostic tests. Clin Infect Dis (2010) 0.98
Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF. AIDS Res Hum Retroviruses (2004) 0.97
Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations. PLoS One (2012) 0.96
Molecular dynamics analysis of HIV-1 matrix protein: clarifying differences between crystallographic and solution structures. J Mol Graph Model (2006) 0.96
Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis (2009) 0.95
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique. Arch Virol (2008) 0.95
Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure. Pediatr Infect Dis J (2009) 0.95
In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes. J Infect Dis (2012) 0.94
The dolabellane diterpene Dolabelladienetriol is a typical noncompetitive inhibitor of HIV-1 reverse transcriptase enzyme. Antiviral Res (2007) 0.91
Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. J Clin Microbiol (2004) 0.91
Impact of asymptomatic Plasmodium falciparum parasitemia on the imunohematological indices among school children and adolescents in a rural area highly endemic for malaria in southern Mozambique. BMC Infect Dis (2013) 0.89
Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage. J Antimicrob Chemother (2009) 0.88
Primary HIV-1 drug resistance in Brazil. AIDS (2004) 0.88
Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood. J Immunol Methods (2011) 0.88
Accumulation of P(T/S)AP late domain duplications in HIV type 1 subtypes B, C, and F derived from individuals failing ARV therapy and ARV drug-naive patients. AIDS Res Hum Retroviruses (2011) 0.87
Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naïve human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. Antimicrob Agents Chemother (2002) 0.87
Assessment of measles immunity among infants in Maputo City, Mozambique. BMC Public Health (2008) 0.87
Sexual transmission of HIV-1 isolate showing G-->A hypermutation. J Clin Virol (2002) 0.86
Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates. J Antimicrob Chemother (2008) 0.86
IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment. AIDS (2009) 0.85
Evaluation of a high-throughput diagnostic system for detection of HIV-1 in dried blood spot samples from infants in Mozambique. J Clin Microbiol (2012) 0.85
Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique. Transfusion (2009) 0.85
Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy. J Clin Virol (2004) 0.83
The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase. Curr HIV Res (2008) 0.83
Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique. PLoS One (2013) 0.82
Vaccine research, development, and innovation in Brazil: a translational science perspective. Vaccine (2013) 0.82
Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. AIDS Res Hum Retroviruses (2010) 0.82
Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors. Transfusion (2007) 0.81
Alternative, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J (2004) 0.81
Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS (2017) 0.80
Crystallization of a non-B and a B mutant HIV protease. Acta Crystallogr D Biol Crystallogr (2004) 0.80
Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C. PLoS One (2012) 0.79
Enhanced Th17 phenotype in uninfected neonates born from viremic HIV-1-infected pregnant women. J Clin Immunol (2010) 0.79
Human leukocyte antigen-A, -B, and -DRB1 allele and haplotype frequencies in the Mozambican population: a blood donor-based population study. Hum Immunol (2010) 0.79
Genotypic analysis of the gp41 HR1 region from HIV-1 isolates from enfuvirtide-treated and untreated patients. J Acquir Immune Defic Syndr (2011) 0.79
Gene polymorphisms in patients with pulmonary tuberculosis from Mozambique. Mol Biol Rep (2014) 0.78
Interactions between SIVNef, SIVGagPol and Alix correlate with viral replication and progression to AIDS in rhesus macaques. Virology (2009) 0.78
Evaluating operational specifications of point-of-care diagnostic tests: a standardized scorecard. PLoS One (2012) 0.78
CCR5 chemokine receptor gene evolution in New World monkeys (Platyrrhini, Primates): implication on resistance to lentiviruses. Infect Genet Evol (2004) 0.77
Effect of serine-type protease of Candida spp. isolated from linear gingival erythema of HIV-positive children: critical factors in the colonization. J Oral Pathol Med (2010) 0.77
Production of the HIV-suppressive chemokines CCL3/MIP-1alpha and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected children. Pediatr Infect Dis J (2007) 0.77
Gag-Pol bearing a reverse transcriptase drug-resistant mutation influences viral genomic RNA incorporation into human immunodeficiency virus type 1 particles. J Gen Virol (2006) 0.77
DBCollHIV: a database system for collaborative HIV analysis in Brazil. Genet Mol Res (2006) 0.77
Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production. AIDS (2007) 0.77
Natural transmission of feline immunodeficiency virus from infected queen to kitten. Virol J (2012) 0.77
Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy. J Clin Virol (2003) 0.76
Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic. PLoS Negl Trop Dis (2011) 0.76
Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique. Virol J (2011) 0.76
Prevalence of etravirine-associated mutations in clinical samples with genotypic resistance to nevirapine and efavirenz in Brazilian clinics. J Acquir Immune Defic Syndr (2011) 0.76
Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, Mozambique. AIDS Res Hum Retroviruses (2013) 0.75
Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification. Antimicrob Agents Chemother (2006) 0.75
Failure of highly active antiretroviral therapy in reconstituting immune response to Clostridium tetani vaccine in aged AIDS patients. J Acquir Immune Defic Syndr (2010) 0.75
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. AIDS (2017) 0.75
Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil. An Acad Bras Cienc (2004) 0.75
Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors. Farmaco (2003) 0.75